A potential therapeutic strategy to inhibit tau protein
aggregation
in neurons has substantial effects on preventing or controlling Alzheimer’s
disease (AD). In this work, we designed a covalent and noncovalent
conjugation of β-boswellic acid (BA) to gold nanoparticles (GNPs).
We provided the opportunity to investigate the effect of the surface
composition of BA-GNPs on the aggregation of the tau protein 1N/4R
isoform in vitro. HR-TEM and FESEM micrographs revealed that GNPs
were spherical and uniform, smaller than 25 nm. According to UV–visible
and FTIR data, BA was successfully conjugated to GNPs. The finding
illustrates the effect of the surface charge, size, and hydrophobicity
of BA-GNPs on the kinetics of tau protein aggregation. The size and
surface area of U-G-BA demonstrated that inhibited tau aggregation
more effectively than covalently linked BA. The proposed method for
preventing tau aggregation was monomer reduction. At the same time,
a chaperone-like feature of GNP-BA while sustaining a tau native structure
prevented the additional formation of fibrils. Overall, this study
provides insight into the interaction of GNP-BAs with a monomer of
tau protein and may suggest novel future therapies for AD.